David J. Beebe is a John D. MacArthur Professor, the Claude Bernard Professor of Biomedical Engineering. He has appointments in the Department of Pathology and Laboratory Medicine and the Department of Biomedical Engineering at the University of Wisconsin-Madison. From 2012-2017 he co-led the Tumor Microenvironment Program in the University of Wisconsin Carbone Cancer Center. He has published more than 250 archived journal articles with more than 30,000 citations (h-index of 72). He is the recipient of the IEEE EMBS Early Career Achievement Award, the Lab on a Chip Royal Society of Chemistry/Corning Pioneers of Miniaturization Prize, the Romnes Award and the Byron Bird Award for Excellence in a Research Publication at UW-Madison and is a Fellow of the American Institute for Medical and Biological Engineering and the Royal Society of Chemistry. David’s current interests center around the creation and use of microfluidic tools to understand cancer biology and improve cancer diagnosis and monitoring. Prof. Beebe is also the co-founder of multiple biotechnology companies and over 30 issued patents. He has mentored over 70 graduate students, post-docs and visiting scientists in his laboratory over the past 20 years who have gone on to success in industry and academia (including faculty positions at Stanford, University of Washington, Iowa State, Vanderbilt, North Carolina State University, University of Pittsburgh and University of Illinois-Chicago).Prof. Beebe’s research has focused on the novel and simple use of microscale physics and phenomena to create tools and methods to further biological and medical goals ranging from basic science to research tools to diagnostics to drug delivery. He pioneered several areas including passive microfluidic mixing, embryo culture and manipulation in microchannels, autonomous microfluidic systems using stimuli responsive hydrogels and passive pumping in microfluidics. From 2004-2009 he completed a 5 year NIH funded retraining in cancer biology. His current research interests center on cellular scale phenomena from both a physical and biological sciences perspective. Specifically, engineering cellular scale systems and applying them to better understand basic cellular processes relevant to cancer. Current projects include analysis of circulating tumor cells from breast and prostate cancer patients, in vitro models of cancer invasion, development of tools to study chemotaxis and immune response, development of functional cell-based assays (adhesion, compartmentalized co-culture, cell-matrix interactions). Emerging research interests include multi-kingdom interactions and the intersection of stress, inflammation and mindfulness.